CNY 25.67
(-0.62%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 8.63 Billion CNY | 3.29% |
2022 | 7.86 Billion CNY | 27.13% |
2021 | 6.18 Billion CNY | 23.86% |
2020 | 4.99 Billion CNY | 24.54% |
2019 | 4 Billion CNY | 45.95% |
2018 | 2.74 Billion CNY | 42.7% |
2017 | 1.92 Billion CNY | 30.12% |
2016 | 1.47 Billion CNY | 32.5% |
2015 | 1.11 Billion CNY | 25.86% |
2014 | 886.99 Million CNY | 27.17% |
2013 | 697.46 Million CNY | 21.65% |
2012 | 573.33 Million CNY | 30.3% |
2011 | 440 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 2.22 Billion CNY | -4.21% |
2024 Q3 | 2.22 Billion CNY | 0.04% |
2024 Q1 | 2.32 Billion CNY | 5.11% |
2023 Q2 | 2.19 Billion CNY | 5.0% |
2023 Q1 | 2.08 Billion CNY | -12.88% |
2023 FY | 8.11 Billion CNY | 3.29% |
2023 Q4 | 2.2 Billion CNY | 10.28% |
2023 Q3 | 2 Billion CNY | -8.73% |
2022 Q4 | 2.39 Billion CNY | 27.02% |
2022 Q3 | 1.88 Billion CNY | 0.54% |
2022 Q2 | 1.87 Billion CNY | 10.52% |
2022 Q1 | 1.69 Billion CNY | 0.9% |
2022 FY | 7.86 Billion CNY | 27.13% |
2021 Q2 | 1.52 Billion CNY | 3.86% |
2021 FY | 6.18 Billion CNY | 23.86% |
2021 Q1 | 1.47 Billion CNY | 8.19% |
2021 Q3 | 1.49 Billion CNY | -1.87% |
2021 Q4 | 1.68 Billion CNY | 12.24% |
2020 Q2 | 1.23 Billion CNY | 5.9% |
2020 Q3 | 1.23 Billion CNY | 0.26% |
2020 Q4 | 1.36 Billion CNY | 10.08% |
2020 FY | 4.99 Billion CNY | 24.54% |
2020 Q1 | 1.16 Billion CNY | 7.69% |
2019 Q4 | 1.08 Billion CNY | 13.21% |
2019 Q1 | 974.57 Million CNY | 13.68% |
2019 FY | 4 Billion CNY | 45.95% |
2019 Q2 | 998.69 Million CNY | 2.48% |
2019 Q3 | 954.6 Million CNY | -4.42% |
2018 Q4 | 857.28 Million CNY | 27.11% |
2018 FY | 2.74 Billion CNY | 42.7% |
2018 Q3 | 674.45 Million CNY | 8.71% |
2018 Q2 | 620.39 Million CNY | 4.38% |
2018 Q1 | 594.35 Million CNY | 8.36% |
2017 FY | 1.92 Billion CNY | 30.12% |
2017 Q1 | 428.01 Million CNY | 1.27% |
2017 Q2 | 463.38 Million CNY | 8.26% |
2017 Q3 | 484.75 Million CNY | 4.61% |
2017 Q4 | 548.51 Million CNY | 13.15% |
2016 Q2 | 361.64 Million CNY | 9.8% |
2016 Q3 | 365.49 Million CNY | 1.07% |
2016 Q4 | 422.64 Million CNY | 15.64% |
2016 FY | 1.47 Billion CNY | 32.5% |
2016 Q1 | 329.37 Million CNY | 1.41% |
2015 Q4 | 324.77 Million CNY | 22.31% |
2015 Q3 | 265.54 Million CNY | -1.25% |
2015 Q2 | 268.89 Million CNY | 4.57% |
2015 Q1 | 257.13 Million CNY | 1.61% |
2015 FY | 1.11 Billion CNY | 25.86% |
2014 Q1 | 199.95 Million CNY | 0.0% |
2014 FY | 886.99 Million CNY | 27.17% |
2014 Q4 | 253.06 Million CNY | 15.02% |
2014 Q3 | 220.01 Million CNY | 2.84% |
2014 Q2 | 213.94 Million CNY | 6.99% |
2013 FY | 697.46 Million CNY | 21.65% |
2012 FY | 573.33 Million CNY | 30.3% |
2011 FY | 440 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 347.55 Million CNY | -2383.246% |
Jointown Pharmaceutical Group Co., Ltd | 11.1 Billion CNY | 22.298% |
LBX Pharmacy Chain Joint Stock Company | 5.77 Billion CNY | -49.551% |
Yunnan Jianzhijia Health-Chain Co., Ltd. | 3.25 Billion CNY | -164.912% |